Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the research and development of monoclonal antibodies for the treatment and diagnosis of cancer and viral infections.
Peregrine Pharmaceuticals, Inc.
14282 Franklin Avenue
Tustin, CA 92780
United States - Map
PPHM used to be $5- $6 stock back on September but again this stock crashed and price went down under the range of 1 $. Now it is breaking that $1 range and trading over a dollar... unusual volume...and buying pressure .... news driven price lets see on 12/10/2012 it may trade more higher because of earning release. Showing good signs to go more higher.
Peregrine Pharmaceuticals Corporation (NASDAQ:PPHM)
Expected next earnings release:
Announcement date: 12/10/2012 - After Market
Earnings Quarter: Q2
Announcement Status: Verified
Sentiment : Hold and wait for more positive news.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.